2016 Hematological Malignancies

HD11: Second Neoplasias

10-year estimate [95%-CI] ABVD+30Gy 5.8% [2.7% to 9.0%] ABVD+20Gy 6.5% [3.7% to 9.3%] Bbas+30Gy 6.7% [3.7% to 9.7%] Bbas+20Gy 5.4% [2.5% to 8.3%] Median observation time 106 months

14

113

285

356

 No difference in the SIR: A= 1.4, B= 2.4, C= 2.2, D= 1.7 compared to the age- and sex-specific incidence in the German general population